Twenty-four-hour treatment of λ-MYC lymphoma cells with increasing amounts of PV1019 led to progressive reduction of MYC protein level (Fig. 5d, left panel), without affecting the stability of the protein (Supplementary Fig. 7c). The gene discussed is MYC; the disease is lymphoma.